VISENTIN, ROBERTO

VISENTIN, ROBERTO  

Dipartimento di Ingegneria dell'Informazione - DEI  

Mostra records
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.059 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 2015 DEL FAVERO, SIMONEVISENTIN, ROBERTOMONARO, MARCOBOSCARI, FEDERICOGALASSO, SILVIAAVOGARO, ANGELOBRUTTOMESSO, DANIELACOBELLI, CLAUDIO + THE LANCET DIABETES & ENDOCRINOLOGY - -
Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus 2017 FACCIOLI, SIMONEDEL FAVERO, SIMONEVISENTIN, ROBERTOBRUTTOMESSO, DANIELACOBELLI, CLAUDIO + JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY - -
Circadian variability of insulin sensitivity: Physiological input for in silico artificial pancreas 2015 VISENTIN, ROBERTODALLA MAN, CHIARACOBELLI, CLAUDIO + DIABETES TECHNOLOGY & THERAPEUTICS - -
Closing the Loop 2017 S Del FaveroF BoscariR VisentinR CaloreS GalassoA GalderisiV ValloneF Di PalmaE LosioukA AvogaroD ChernavvskyL MagniC CobelliD BruttomessoD BruttomessoR VisentinR CaloreF Di PalmaP MagniF BoscariS GalassoA AvogaroS Del FaveroC CobelliL MagniS Del FaveroR VisentinM MonaroF Di PalmaF BoscariS GalassoP MagniA AvogaroD BruttomessoC CobelliL Magni + DIABETES TECHNOLOGY & THERAPEUTICS - -
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 2016 BRUTTOMESSO, DANIELAVISENTIN, ROBERTOCALORE, ROBERTABOSCARI, FEDERICOGALASSO, SILVIAAVOGARO, ANGELODEL FAVERO, SIMONECOBELLI, CLAUDIO + DIABETES CARE - -
Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study 2021 Dalla Man C.Visentin R. + METABOLISM, CLINICAL AND EXPERIMENTAL - -
Dual glucagon-like peptide-1 receptor/glucagon receptor agonist SAR425899 improves beta-cell function in type 2 diabetes 2020 Visentin R.Schiavon M.Cobelli C.Dalla Man C. + DIABETES, OBESITY AND METABOLISM - -
Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting 2016 Galderisi, AlfonsoVallone, ValeriaBoscari, FedericoDel Favero, SimoneGalasso, SilviaDi Palma, FedericoVisentin, RobertoCalore, RobertaLeal, YennyMagni, LaloLosiouk, EleonoraChernavvsky, DanielCobelli, ClaudioBruttomesso, Daniela + DIABETES CARE - -
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. 2013 COBELLI, CLAUDIOBRUTTOMESSO, DANIELADEL FAVERO, SIMONEVISENTIN, ROBERTOSCOTTON, RACHELEAVOGARO, ANGELO + DIABETES CARE - -
First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas 2014 DEL FAVERO, SIMONEBRUTTOMESSO, DANIELAVISENTIN, ROBERTOSCOTTON, RACHELEAVOGARO, ANGELOCOBELLI, CLAUDIO + DIABETES CARE - -
Hepatic insulin sensitivity in healthy and prediabetic subjects: From a dual- to a single-tracer oral minimal model 2015 VISENTIN, ROBERTODALLA MAN, CHIARACOBELLI, CLAUDIO + AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM - -
Il pancreas artificiale in età  pediatrica: Prima esperienza Italiana 2016 Boscari, F.Del Favero, S.Visentin, R.Calore, R.LEAL MONCADA, YENNY TERESAGalasso, S.Galderisi, A.Vallone, V.Di Palma, F.Losiouk, EleonoraAvogaro, A.Magni, L.Cobelli, C.Bruttomesso, Daniela + GIDM. GIORNALE ITALIANO DI DIABETOLOGIA E METABOLISMO - -
Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide 2021 Schiavon M.Visentin R.Riz M.Cobelli C.Dalla Man C. + DIABETES, OBESITY AND METABOLISM - -
Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator 2016 VISENTIN, ROBERTODALLA MAN, CHIARACOBELLI, CLAUDIO + DIABETES TECHNOLOGY & THERAPEUTICS - -
In silico head-to-head comparison of insulin glargine 300 U/mL and insulin degludec 100 U/mL in type 1 diabetes 2020 Schiavon M.Visentin R.Dalla Man C.Cobelli C. + DIABETES TECHNOLOGY & THERAPEUTICS - -
Incorporating long-acting insulin glargine into the UVA/Padova type 1 diabetes simulator for in silico testing of MDI therapies 2019 Visentin R.Schiavon M.Dalla Man C.Cobelli C. + IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING - -
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions 2017 Del Favero, SimoneVisentin, RobertoCalore, RobertaDi Palma, FedericoBoscari, FedericoGalasso, SilviaAvogaro, AngeloBruttomesso, DanielaMAGNI, LALOCobelli, Claudio + DIABETES TECHNOLOGY & THERAPEUTICS - -
Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids 2019 Dalla Man C.Visentin R. + DIABETOLOGIA - -
Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes 2020 Schiavon, MicheleVisentin, RobertoCobelli, ClaudioDalla Man, Chiara + IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING - -
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes 2015 DEL FAVERO, SIMONEVISENTIN, ROBERTOMONARO, MARCOGALASSO, SILVIABOSCARI, FEDERICODI PALMA, FEDERICOAVOGARO, ANGELOBRUTTOMESSO, DANIELACOBELLI, CLAUDIO + DIABETES, OBESITY AND METABOLISM - -